Literature DB >> 14631179

Update on the etiology, diagnosis, and treatment of vocal fold nodules, polyps, and cysts.

Michael M Johns1.   

Abstract

PURPOSE OF REVIEW: Innovative otolaryngologists, speech language pathologists, and voice scientists have continued to advance our understanding of the etiology, diagnosis, and treatment of vocal fold nodules, polyps, and cysts. This article reviews the recent publications over the past 3 years with respect to these advances. RECENT
FINDINGS: Support for the notion that benign vocal fold lesions arise from phonatory trauma and vocal misuse continues to become evident. Changes in the molecular characteristics of the lamina propria in these lesions are beginning to be understood. For diagnostic purposes, the use of innovative technology such as ultrasonography and virtual laryngoscopy is being explored. Continued support for behavior modification as a primary treatment modality for benign vocal fold lesions has been published, and refinements in technical aspects of laryngeal microsurgery persist. Finally, outcomes studies have demonstrated improvements in vocal disability with both behavioral and surgical interventions.
SUMMARY: Clinical and basic research has furthered our understanding of benign vocal fold lesions and has expanded our diagnostic and therapeutic armamentarium for patients with dysphonia arising from these lesions.

Entities:  

Mesh:

Year:  2003        PMID: 14631179     DOI: 10.1097/00020840-200312000-00009

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  33 in total

1.  The use of narrow band imaging for the detection of benign lesions of the larynx.

Authors:  Sebastian Dippold; Manfred Nusseck; Bernhard Richter; Matthias Echternach
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-08       Impact factor: 2.503

2.  Effect of voice therapy on vocal fold polyp treatment.

Authors:  Mustafa Sahin; Sercan Gode; Murat Dogan; Tayfun Kirazli; Fatih Ogut
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-06       Impact factor: 2.503

Review 3.  Hoarseness-causes and treatments.

Authors:  Rudolf Reiter; Thomas Karl Hoffmann; Anja Pickhard; Sibylle Brosch
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

4.  Proposed computerized protocol for epidemiological study of patients undergoing microsurgery of the larynx.

Authors:  Guilherme Simas do Amaral Catani; Bettina Carvalho; Jorge Massaaki Ido Filho; Evaldo Dacheux de Macedo Filho; José Simão de Paula Pinto; Osvaldo Malafaia; Henrique Jorge Stahlke
Journal:  Int Arch Otorhinolaryngol       Date:  2012-07

5.  In Situ Visualization for 3D Agent-Based Vocal Fold Inflammation and Repair Simulation.

Authors:  Nuttiiya Seekhao; Joseph JaJa; Luc Mongeau; Nicole Y K Li-Jessen
Journal:  Supercomput Front Innov       Date:  2017 Jul-Sep

6.  β-Defensin-2 is overexpressed in human vocal cord polyps.

Authors:  Jinjin Gu; Yongwang Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-01       Impact factor: 2.503

7.  Factors Influencing Likelihood of Voice Therapy Attendance.

Authors:  Stephanie Misono; Schelomo Marmor; Nelson Roy; Ted Mau; Seth M Cohen
Journal:  Otolaryngol Head Neck Surg       Date:  2016-11-26       Impact factor: 3.497

8.  Mechanotransduction of vocal fold fibroblasts and mesenchymal stromal cells in the context of the vocal fold mechanome.

Authors:  Rebecca S Bartlett; Joel D Gaston; Shuyun Ye; Christina Kendziorski; Susan L Thibeault
Journal:  J Biomech       Date:  2018-12-07       Impact factor: 2.712

9.  The Clinicopathological Study of Benign Lesions of Vocal Cords.

Authors:  Priya Malik; S P S Yadav; Rajeev Sen; Pansi Gupta; Jai Singh; Aditi Singla; Swati Vashisht
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-11-30

10.  Spatiotemporal analysis of normal and pathological human vocal fold vibrations.

Authors:  Christopher R Krausert; Yufang Liang; Yu Zhang; Adam L Rieves; Kyle R Geurink; Jack J Jiang
Journal:  Am J Otolaryngol       Date:  2012-07-26       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.